[Phospholipids of pulmonary surfactants and lung elasticity].
We discuss the various preparations of substitute pulmonary surfactant that have been proposed for the treatment of Respiratory Distress Syndrome in premature infants. We than submit some experimental results demonstrating that a preparation of phospholipids in an organic solvent can simulate the behavior of the naturally occurring pulmonary surfactant as a monolayer at an air-water interface.
D006801:Humans; D007231:Infant, Newborn; D008168:Lung / Q000502:physiology*; D010743:Phospholipids / Q000502:physiology* / Q000627:therapeutic use; D011663:Pulmonary Surfactants / Q000502:physiology*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy
D010743:Phospholipids; D011663:Pulmonary Surfactants
Les phospholipides du surfactant pulmonaire et l'élasticité des poumons.